Skip to content
10-K

Annual Report

Renalytix plc RENXF RNLXY

0000950170-24-110315

← back to feed
Filed
Sep 30, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Sep 16, 2024 165.93M sh
Shares Diluted FY 2024 · Jun 30, 2024 108.18M sh
Shares Diluted FY 2024 · Jun 30, 2023 82.21M sh
Operating Cash Flow FY 2024 · Jun 30, 2024 −$30.11M
Operating Cash Flow FY 2024 · Jun 30, 2023 −$34.09M
Cash And Equivalents FY 2024 · Jun 30, 2024 $4.68M
Cash And Equivalents FY 2024 · Jun 30, 2023 $24.68M
Stockholders Equity FY 2024 · Jun 30, 2024 −$7.85M
Stockholders Equity FY 2024 · Jun 30, 2023 $6.97M
Stockholders Equity FY 2024 · Jun 30, 2022 $30.61M
Current Liabilities FY 2024 · Jun 30, 2024 $11.5M
Current Liabilities FY 2024 · Jun 30, 2023 $16.14M
Total Liabilities FY 2024 · Jun 30, 2024 $15.83M
Total Liabilities FY 2024 · Jun 30, 2023 $23.66M
Current Assets FY 2024 · Jun 30, 2024 $6.12M
Current Assets FY 2024 · Jun 30, 2023 $26.88M
Total Assets FY 2024 · Jun 30, 2024 $7.97M
Total Assets FY 2024 · Jun 30, 2023 $30.63M
Eps Diluted FY 2024 · Jun 30, 2024 −$0.31
Eps Diluted FY 2024 · Jun 30, 2023 −$0.55
Eps Basic FY 2024 · Jun 30, 2024 −$0.31
Eps Basic FY 2024 · Jun 30, 2023 −$0.55
Sga Expense FY 2024 · Jun 30, 2024 $19.75M
Sga Expense FY 2024 · Jun 30, 2023 $28.66M
Net Income FY 2024 · Jun 30, 2024 −$33.46M
Net Income FY 2024 · Jun 30, 2023 −$45.61M
Operating Income FY 2024 · Jun 30, 2024 −$29.61M
Operating Income FY 2024 · Jun 30, 2023 −$42.22M
Gross Profit FY 2024 · Jun 30, 2024 $156K
Gross Profit FY 2024 · Jun 30, 2023 $720K
Cost Of Revenue FY 2024 · Jun 30, 2024 $2.13M
Cost Of Revenue FY 2024 · Jun 30, 2023 $2.68M